Basic helix-loop-helix transcriptional factor MyoR regulates BMP-7 in acute kidney injury

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 9, 2013, Pages

  Kamiura, Nozomu ^a   Hirahashi, Junichi ^a   Matsuzaki, Yumi ^b   Idei, Mana ^a   Takase, Osamu ^a   Fujita, Toshiro ^a   Takato, Tsuyoshi ^c   Hishikawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

AKI; BMP 7; Stem cell

Indexed keywords

CISPLATIN; OSTEOGENIC PROTEIN 1; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MYOR; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; DISEASE SEVERITY; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84878598906     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00510.2012     Document Type: Article

References (24)

1. Challen GA, Bertoncello I, Deane JA, Ricardo SD, Little MH. Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 17: 1896-1912, 2006.
2. Chen X, Wang J, Fu B, Yu L. RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys. Biochem Biophys Res Commun 234: 594-599, 1997.
3. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine (Phila Pa 1976) 27: S10-15, 2002.
4. Feng JQ, Chen D, Cooney AJ, Tsai MJ, Harris MA, Tsai SY, Feng M, Mundy GR, Harris SE. The mouse bone morphogenetic protein-4 gene. Analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP-TFI orphan receptor. J Biol Chem 270: 28364- 28373, 1995.
5. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806, 1996.
6. Hirahashi J, Takayanagi A, Hishikawa K, Takase O, Chikaraishi A, Hayashi M, Shimizu N, Saruta T. Overexpression of truncated I kappa B alpha potentiates TNF-alpha-induced apoptosis in mesangial cells. Kidney Int 57: 959-968, 2000.
7. Hishikawa K, Marumo T, Miura S, Nakanishi A, Matsuzaki Y, Shibata K, Ichiyanagi T, Kohike H, Komori T, Takahashi I, Takase O, Imai N, Yoshikawa M, Inowa T, Hayashi M, Nakaki T, Nakauchi H, Okano H, Fujita T. Musculin/MyoR is expressed in kidney side population cells and can regulate their function. J Cell Biol 169: 921-928, 2005.
8. Hishikawa K, Marumo T, Miura S, Nakanishi A, Matsuzaki Y, Shibata K, Kohike H, Komori T, Hayashi M, Nakaki T, Nakauchi H, Okano H, Fujita T. Leukemia inhibitory factor induces multi-lineage differentiation of adult stem-like cells in kidney via kidney-specific cad-herin 16. Biochem Biophys Res Commun 328: 288-291, 2005.
9. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402, 2001.
10. Lu J, Webb R, Richardson JA, Olson EN. MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci USA 96: 552-557, 1999.
11. Lu JR, Bassel-Duby R, Hawkins A, Chang P, Valdez R, Wu H, Gan L, Shelton JM, Richardson JA, Olson EN. Control of facial muscle development by MyoR and capsulin. Science 298: 2378-2381, 2002.
12. Majka SM, Jackson KA, Kienstra KA, Majesky MW, Goodell MA, Hirschi KK. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111: 71-79, 2003.
13. Marumo T, Hishikawa K, Yoshikawa M, Fujita T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol 19: 1311-1320, 2008.
14. Matsuzaki Y, Kinjo K, Mulligan RC, Okano H. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 20: 87-93, 2004.
15. Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20: 1754-1764, 2009.
16. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002.
17. Robb L, Hartley L, Wang CC, Harvey RP, Begley CG. musculin: a murine basic helix-loop-helix transcription factor gene expressed in embryonic skeletal muscle. Mech Dev 76: 197-201, 1998.
18. Rosenthal N. Machinations of the marrow. J Clin Invest 111: 29-30, 2003.
19. Takase O, Hirahashi J, Takayanagi A, Chikaraishi A, Marumo T, Ozawa Y, Hayashi M, Shimizu N, Saruta T. Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury. Kidney Int 63: 501-513, 2003.
20. Uchida N, Fujisaki T, Eaves AC, Eaves CJ. Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP) phenotype. J Clin Invest 108: 1071-1077, 2001.
21. Wang S, Hirschberg R. BMP7 antagonizes TGF-fj-dependent fibrogen-esis in mesangial cells. Am J Physiol Renal Physiol 284: F1006-F1013, 2003.
22. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE. MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37: 783-792, 1990.
23. Yu L, Mikloucich J, Sangster N, Perez A, McCormick PJ. MyoR is expressed in nonmyogenic cells and can inhibit their differentiation. Exp Cell Res 289: 162-173, 2003.
24. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mes-enchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.